IFNA2 and systemic lupus erythematosus: SLE pathogenesis is characterized by inflammasome overactivation; one study demonstrated that prolonged IFNα treatment increased inflammasome activity, which was eliminated with knockdown of IRF1 in SLE monocytes (49).